Has George Varghese, MD received payments from drug or device companies?

Yes. Drug and device makers reported $548 in general payments to George Varghese, MD across 10 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean George Varghese, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about George Varghese, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

George Varghese, MD

Dermatology · New York, NYNPI 1912226507

Payments from drug & device makers

$548in general payments, 2019–2025

Across 10 payments — averaging $54.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$333
Alnylam Pharmaceuticals Inc.$123
AbbVie$43
Organon$31
Pfizer$18

What the payments were for

Food & beverage$35364%
Education$19536%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	4	$333
Alnylam Pharmaceuticals Inc.	1	$123
AbbVie	2	$43
Organon	2	$31
Pfizer	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Tremfya$125
AMVUTTRA$123

How this compares

$548 in reported general payments places this provider in the 25th percentile of 1,151 dermatology providers in New York.

See all dermatology providers in New York →

Medicare billing

Part B allowed, 2024

$168,384

Medicare patients

529

Services billed

1,903

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tacrolimus	45	$7,175
Betamethasone Dipropionate	54	$2,131
Fluorouracil	38	$1,992
Triamcinolone Acetonide	152	$1,711
Fluocinonide	37	$1,274
Metronidazole	33	$1,113
Clindamycin Phosphate	18	$922
Clobetasol Propionate	26	$861
Gabapentin	49	$638
CiclopiroxCiclopirox Olamine	35	$631
Mupirocin	66	$510
Doxycycline Hyclate	31	$475
Mometasone Furoate	32	$463
ValacyclovirValacyclovir Hcl	23	$411
Hydrocortisone	82	$335

Paid to pharmacies, not to this prescriber.

Other dermatology in New York

Emma GuttmanNew York$35.3M
Saakshi KhattriNew York$15.4M
James KruegerNew York$6.3M
Michael CameronNew York$5.8M
Mark LebwohlNew York$5.8M
Andrew AlexisNew York$5.7M
Neil SadickNew York$4.2M
Orit MarkowitzNew York$3.7M
Alexandra GolantNew York$3.6M
George HanNew York$3.4M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →